The National Trial Lawyers
  • Home
    • Meet Our Team
    • Contact Us
    • Mission & Goals
    • FAQ
  • Webinars
  • News
  • Membership Directory
    • Top 100 Map – Civil Plaintiff
    • Top 100 Map – Criminal Defense
    • Top 40 Under 40 Map – Civil Plaintiff
    • Top 40 Under 40 Map – Criminal Defense
  • Top 100
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Benefits
    • About
    • Top 100 Presidents Message
    • Diplomat
    • Membership Renewal
    • Member Profile Updates
    • Top 100 Badge
  • Top 40
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Top 40 Under 40 Trial Academy Bootcamp
    • Benefits
    • About
    • Top 40 Presidents Message
    • Membership Renewal
    • Member Profile Updates
    • Top 40 Badge
  • Specialty Assoc
    • About
    • Shop
    • Officers
    • Membership Renewal
    • Member Profile Updates
  • Nominate
    • Top 100
    • Top 40
    • Specialty Association
    • Trial Lawyer Hall of Fame
    • Trial Lawyer of the Year
    • Trial Team of the Year
    • America’s Most Influential Trial Lawyer
    • America’s Most Influential Law Firm
    • Lifetime Achievement Award
  • Shop
  • Magazine
    • A-List
  • Education and Networking Agenda
    • Trial Lawyers Summit
    • Top 40 Under 40 Trial Academy Boot Camp
    • Mass Torts Made Perfect
    • The Lanier Trial Academy Master Class 6.0
    • The Business Of Law
    • Webinars
  • Hall of Fame
    • Trial Lawyer Hall of Fame

Stevens Johnson Syndrome: Zithromax Maker Warned About Zmax

Posted on March 12, 2013 by Andrew Findley


Lawyersandsettlements.com; March 11, 2013

New York, NY: Drug companies often face criticism that they downplay the risk of side effects, especially the risk of serious side effects such as Stevens Johnson Syndrome. In some cases, the US Food and Drug Administration (FDA) gets involved, as it did when it sent a warning letter about the risk of azithromycin side effects to the drug’s maker. Although many drugs linked to SJS include a warning about a possible allergic reaction, patients who developed SJS say the warning was not adequate, given the severity of the situation.
Many medications that have been linked to Stevens Johnson Syndrome do not give specific warnings about what the condition looks like or how serious it can be. They simply warn that an allergic reaction can occur and if a rash appears, the patient should seek medical attention. But in some cases the condition the medication is treating also causes a rash, causing patients to believe the rash is linked to their being ill, not to taking the medication.

Although technically Stevens Johnson Syndrome is indeed an allergic reaction to medication – even medication that has been previously tolerated by the patient – referring to Stevens Johnson Syndrome as an allergic reaction as opposed to a life-threatening reaction might not convey the severity of the situation.

Drug companies – including Pfizer, maker of Zithromax – have been warned by the FDA not to minimize the risks of Stevens Johnson Syndrome. On June 19, 2012, the FDA sent a warning letter to Pfizer (found online at www.fda.gov), regarding the company’s “1 Day. 1 Dose” brochure for a drug called Zmax (azithromycin extended-release medication). The agency warned Pfizer that its brochure did not explain the severity of Stevens Johnson Syndrome – which can be fatal – and further did not note that some patients experienced continued severe allergic symptoms even after they stopped taking Zmax (the warning label did note that some symptoms recurred without further exposure to the drug but did not note how severe those symptoms were).

Zmax is used to treat mild to moderate infections including acute bacterial sinusitis and community-acquired pneumonia. Stevens Johnson Syndrome is a potentially fatal allergic reaction to medications including azithromycin. It often starts with a rash and swelling, and develops to the point where the patient’s skin sloughs off. Often the patient suffers permanent scarring, organ damage and vision problems.

http://www.lawyersandsettlements.com/articles/zithromax-sjs-lawsuit/zithromax-side-effects-lawsuit-9-18547.html?utm_expid=3607522-0&utm_referrer=http%3A%2F%2Fwww.lawyersandsettlements.com%2F

Posted in Blog, Product Liability

Comments are closed.

Recent Posts

Virginians Will Receive $489 Million in a Payday Loan Settlement

Virginians Will Receive $489 Million in a Payday Loan Settlement

May 18th, 2022

Online payday loan companies that charged as much as 919% interest will spend $489 million to reimburse some 555,000 borrower[Read More...]
The State of Minnesota Will Pay $1.5 Million to a Man Who Alleged Excessive Force During an Arrest

The State of Minnesota Will Pay $1.5 Million to a Man Who Alleged Excessive Force During an Arrest

May 18th, 2022

Minneapolis has agreed to pay $1.5 million to a man who said police used excessive force when he was arrested during the prot[Read More...]
A $230 Million Settlement Is Reached Over a 2015 Southern California Oil Spill

A $230 Million Settlement Is Reached Over a 2015 Southern California Oil Spill

May 16th, 2022

The owner of an oil pipeline that spewed thousands of barrels of crude oil onto Southern California beaches in 2015 has agree[Read More...]
The LeClairRyan-UnitedLex Dispute Reaches a Pending $21 Million Settlement

The LeClairRyan-UnitedLex Dispute Reaches a Pending $21 Million Settlement

May 16th, 2022

After a prolonged mediation process, the LeClairRyan bankruptcy estate looks to have reached a sizable settlement in one of t[Read More...]
The Families of Holyoke Soldiers Home Victims Reach a $56 Million Settlement

The Families of Holyoke Soldiers Home Victims Reach a $56 Million Settlement

May 13th, 2022

Massachusetts has agreed to pay $56 million to settle a class-action lawsuit brought by the families of veterans who died or [Read More...]

Contact Us | Terms of Use | Privacy Policy

Attorney information and content provided on this website is provided for the benefit of members of The National Trial Lawyers and as a public service by Legal Associations Management, Inc. The website and all data are the property of Legal Associations Management, Inc. Data, including without limitation attorney information and content, on the site may not be mined, sold, or used commercially for any purpose without the explicit written consent of Legal Associations Management, Inc. This site may not be accessed by any automated program for extracting data for any use. By accessing and using the site you agree that you will not develop, support or use software, devices, scripts, robots, or any other means or processes (including crawlers, browser plug-ins and add-ons, or any other technology) to scrape data or otherwise copy profiles and other data. Unauthorized use or attempted unauthorized use of this system may subject you to both civil and criminal penalties.